Global Nonsteroidal Antiinflammatory Drugs Market Growth 2025-2031
The report requires updating with new data and is sent in 48 hours after order is placed.
The global Nonsteroidal Antiinflammatory Drugs market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.
Non-steroidal anti-inflammatory drugs refer to a class of drugs that do not contain glucocorticoids and have anti-inflammatory, antipyretic and analgesic effects. It is a first-line drug for the treatment of osteoarthritis and is widely used in other bone and joint diseases, rheumatic and immune diseases and pain diseases.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
LP Information, Inc. (LPI) ' newest research report, the “Nonsteroidal Antiinflammatory Drugs Industry Forecast” looks at past sales and reviews total world Nonsteroidal Antiinflammatory Drugs sales in 2024, providing a comprehensive analysis by region and market sector of projected Nonsteroidal Antiinflammatory Drugs sales for 2025 through 2031. With Nonsteroidal Antiinflammatory Drugs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Nonsteroidal Antiinflammatory Drugs industry.
This Insight Report provides a comprehensive analysis of the global Nonsteroidal Antiinflammatory Drugs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Nonsteroidal Antiinflammatory Drugs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Nonsteroidal Antiinflammatory Drugs market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Nonsteroidal Antiinflammatory Drugs and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Nonsteroidal Antiinflammatory Drugs.
This report presents a comprehensive overview, market shares, and growth opportunities of Nonsteroidal Antiinflammatory Drugs market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Nonsteroidal Antiinflammatory Drugs market?
What factors are driving Nonsteroidal Antiinflammatory Drugs market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Nonsteroidal Antiinflammatory Drugs market opportunities vary by end market size?
How does Nonsteroidal Antiinflammatory Drugs break out by Type, by Application?
The global Nonsteroidal Antiinflammatory Drugs market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.
Non-steroidal anti-inflammatory drugs refer to a class of drugs that do not contain glucocorticoids and have anti-inflammatory, antipyretic and analgesic effects. It is a first-line drug for the treatment of osteoarthritis and is widely used in other bone and joint diseases, rheumatic and immune diseases and pain diseases.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
LP Information, Inc. (LPI) ' newest research report, the “Nonsteroidal Antiinflammatory Drugs Industry Forecast” looks at past sales and reviews total world Nonsteroidal Antiinflammatory Drugs sales in 2024, providing a comprehensive analysis by region and market sector of projected Nonsteroidal Antiinflammatory Drugs sales for 2025 through 2031. With Nonsteroidal Antiinflammatory Drugs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Nonsteroidal Antiinflammatory Drugs industry.
This Insight Report provides a comprehensive analysis of the global Nonsteroidal Antiinflammatory Drugs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Nonsteroidal Antiinflammatory Drugs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Nonsteroidal Antiinflammatory Drugs market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Nonsteroidal Antiinflammatory Drugs and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Nonsteroidal Antiinflammatory Drugs.
This report presents a comprehensive overview, market shares, and growth opportunities of Nonsteroidal Antiinflammatory Drugs market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Oral Nonsteroidal Antiinflammatory Drugs
- Injection Nonsteroidal Antiinflammatory Drugs
- Osteoarthritis
- Muscle Aches
- Backaches
- Dental Pain
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Sanofi S.A.
- Novartis AG
- GlaxoSmithKline PLC
- Pfizer
- DOMESCO
What is the 10-year outlook for the global Nonsteroidal Antiinflammatory Drugs market?
What factors are driving Nonsteroidal Antiinflammatory Drugs market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Nonsteroidal Antiinflammatory Drugs market opportunities vary by end market size?
How does Nonsteroidal Antiinflammatory Drugs break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Nonsteroidal Antiinflammatory Drugs Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Nonsteroidal Antiinflammatory Drugs by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Nonsteroidal Antiinflammatory Drugs by Country/Region, 2020, 2024 & 2031
2.2 Nonsteroidal Antiinflammatory Drugs Segment by Type
2.2.1 Oral Nonsteroidal Antiinflammatory Drugs
2.2.2 Injection Nonsteroidal Antiinflammatory Drugs
2.3 Nonsteroidal Antiinflammatory Drugs Sales by Type
2.3.1 Global Nonsteroidal Antiinflammatory Drugs Sales Market Share by Type (2020-2025)
2.3.2 Global Nonsteroidal Antiinflammatory Drugs Revenue and Market Share by Type (2020-2025)
2.3.3 Global Nonsteroidal Antiinflammatory Drugs Sale Price by Type (2020-2025)
2.4 Nonsteroidal Antiinflammatory Drugs Segment by Application
2.4.1 Osteoarthritis
2.4.2 Muscle Aches
2.4.3 Backaches
2.4.4 Dental Pain
2.4.5 Others
2.5 Nonsteroidal Antiinflammatory Drugs Sales by Application
2.5.1 Global Nonsteroidal Antiinflammatory Drugs Sale Market Share by Application (2020-2025)
2.5.2 Global Nonsteroidal Antiinflammatory Drugs Revenue and Market Share by Application (2020-2025)
2.5.3 Global Nonsteroidal Antiinflammatory Drugs Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Nonsteroidal Antiinflammatory Drugs Breakdown Data by Company
3.1.1 Global Nonsteroidal Antiinflammatory Drugs Annual Sales by Company (2020-2025)
3.1.2 Global Nonsteroidal Antiinflammatory Drugs Sales Market Share by Company (2020-2025)
3.2 Global Nonsteroidal Antiinflammatory Drugs Annual Revenue by Company (2020-2025)
3.2.1 Global Nonsteroidal Antiinflammatory Drugs Revenue by Company (2020-2025)
3.2.2 Global Nonsteroidal Antiinflammatory Drugs Revenue Market Share by Company (2020-2025)
3.3 Global Nonsteroidal Antiinflammatory Drugs Sale Price by Company
3.4 Key Manufacturers Nonsteroidal Antiinflammatory Drugs Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Nonsteroidal Antiinflammatory Drugs Product Location Distribution
3.4.2 Players Nonsteroidal Antiinflammatory Drugs Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR NONSTEROIDAL ANTIINFLAMMATORY DRUGS BY GEOGRAPHIC REGION
4.1 World Historic Nonsteroidal Antiinflammatory Drugs Market Size by Geographic Region (2020-2025)
4.1.1 Global Nonsteroidal Antiinflammatory Drugs Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Nonsteroidal Antiinflammatory Drugs Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Nonsteroidal Antiinflammatory Drugs Market Size by Country/Region (2020-2025)
4.2.1 Global Nonsteroidal Antiinflammatory Drugs Annual Sales by Country/Region (2020-2025)
4.2.2 Global Nonsteroidal Antiinflammatory Drugs Annual Revenue by Country/Region (2020-2025)
4.3 Americas Nonsteroidal Antiinflammatory Drugs Sales Growth
4.4 APAC Nonsteroidal Antiinflammatory Drugs Sales Growth
4.5 Europe Nonsteroidal Antiinflammatory Drugs Sales Growth
4.6 Middle East & Africa Nonsteroidal Antiinflammatory Drugs Sales Growth
5 AMERICAS
5.1 Americas Nonsteroidal Antiinflammatory Drugs Sales by Country
5.1.1 Americas Nonsteroidal Antiinflammatory Drugs Sales by Country (2020-2025)
5.1.2 Americas Nonsteroidal Antiinflammatory Drugs Revenue by Country (2020-2025)
5.2 Americas Nonsteroidal Antiinflammatory Drugs Sales by Type (2020-2025)
5.3 Americas Nonsteroidal Antiinflammatory Drugs Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Nonsteroidal Antiinflammatory Drugs Sales by Region
6.1.1 APAC Nonsteroidal Antiinflammatory Drugs Sales by Region (2020-2025)
6.1.2 APAC Nonsteroidal Antiinflammatory Drugs Revenue by Region (2020-2025)
6.2 APAC Nonsteroidal Antiinflammatory Drugs Sales by Type (2020-2025)
6.3 APAC Nonsteroidal Antiinflammatory Drugs Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Nonsteroidal Antiinflammatory Drugs by Country
7.1.1 Europe Nonsteroidal Antiinflammatory Drugs Sales by Country (2020-2025)
7.1.2 Europe Nonsteroidal Antiinflammatory Drugs Revenue by Country (2020-2025)
7.2 Europe Nonsteroidal Antiinflammatory Drugs Sales by Type (2020-2025)
7.3 Europe Nonsteroidal Antiinflammatory Drugs Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Nonsteroidal Antiinflammatory Drugs by Country
8.1.1 Middle East & Africa Nonsteroidal Antiinflammatory Drugs Sales by Country (2020-2025)
8.1.2 Middle East & Africa Nonsteroidal Antiinflammatory Drugs Revenue by Country (2020-2025)
8.2 Middle East & Africa Nonsteroidal Antiinflammatory Drugs Sales by Type (2020-2025)
8.3 Middle East & Africa Nonsteroidal Antiinflammatory Drugs Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Nonsteroidal Antiinflammatory Drugs
10.3 Manufacturing Process Analysis of Nonsteroidal Antiinflammatory Drugs
10.4 Industry Chain Structure of Nonsteroidal Antiinflammatory Drugs
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Nonsteroidal Antiinflammatory Drugs Distributors
11.3 Nonsteroidal Antiinflammatory Drugs Customer
12 WORLD FORECAST REVIEW FOR NONSTEROIDAL ANTIINFLAMMATORY DRUGS BY GEOGRAPHIC REGION
12.1 Global Nonsteroidal Antiinflammatory Drugs Market Size Forecast by Region
12.1.1 Global Nonsteroidal Antiinflammatory Drugs Forecast by Region (2026-2031)
12.1.2 Global Nonsteroidal Antiinflammatory Drugs Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Nonsteroidal Antiinflammatory Drugs Forecast by Type (2026-2031)
12.7 Global Nonsteroidal Antiinflammatory Drugs Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Sanofi S.A.
13.1.1 Sanofi S.A. Company Information
13.1.2 Sanofi S.A. Nonsteroidal Antiinflammatory Drugs Product Portfolios and Specifications
13.1.3 Sanofi S.A. Nonsteroidal Antiinflammatory Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Sanofi S.A. Main Business Overview
13.1.5 Sanofi S.A. Latest Developments
13.2 Novartis AG
13.2.1 Novartis AG Company Information
13.2.2 Novartis AG Nonsteroidal Antiinflammatory Drugs Product Portfolios and Specifications
13.2.3 Novartis AG Nonsteroidal Antiinflammatory Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Novartis AG Main Business Overview
13.2.5 Novartis AG Latest Developments
13.3 GlaxoSmithKline PLC
13.3.1 GlaxoSmithKline PLC Company Information
13.3.2 GlaxoSmithKline PLC Nonsteroidal Antiinflammatory Drugs Product Portfolios and Specifications
13.3.3 GlaxoSmithKline PLC Nonsteroidal Antiinflammatory Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 GlaxoSmithKline PLC Main Business Overview
13.3.5 GlaxoSmithKline PLC Latest Developments
13.4 Pfizer
13.4.1 Pfizer Company Information
13.4.2 Pfizer Nonsteroidal Antiinflammatory Drugs Product Portfolios and Specifications
13.4.3 Pfizer Nonsteroidal Antiinflammatory Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Pfizer Main Business Overview
13.4.5 Pfizer Latest Developments
13.5 DOMESCO
13.5.1 DOMESCO Company Information
13.5.2 DOMESCO Nonsteroidal Antiinflammatory Drugs Product Portfolios and Specifications
13.5.3 DOMESCO Nonsteroidal Antiinflammatory Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 DOMESCO Main Business Overview
13.5.5 DOMESCO Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OFTABLES
Table 1. Nonsteroidal Antiinflammatory Drugs Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Nonsteroidal Antiinflammatory Drugs Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Oral Nonsteroidal Antiinflammatory Drugs
Table 4. Major Players of Injection Nonsteroidal Antiinflammatory Drugs
Table 5. Global Nonsteroidal Antiinflammatory Drugs Sales byType (2020-2025) & (K Pcs)
Table 6. Global Nonsteroidal Antiinflammatory Drugs Sales Market Share byType (2020-2025)
Table 7. Global Nonsteroidal Antiinflammatory Drugs Revenue byType (2020-2025) & ($ million)
Table 8. Global Nonsteroidal Antiinflammatory Drugs Revenue Market Share byType (2020-2025)
Table 9. Global Nonsteroidal Antiinflammatory Drugs Sale Price byType (2020-2025) & (USD/Pcs)
Table 10. Global Nonsteroidal Antiinflammatory Drugs Sale by Application (2020-2025) & (K Pcs)
Table 11. Global Nonsteroidal Antiinflammatory Drugs Sale Market Share by Application (2020-2025)
Table 12. Global Nonsteroidal Antiinflammatory Drugs Revenue by Application (2020-2025) & ($ million)
Table 13. Global Nonsteroidal Antiinflammatory Drugs Revenue Market Share by Application (2020-2025)
Table 14. Global Nonsteroidal Antiinflammatory Drugs Sale Price by Application (2020-2025) & (USD/Pcs)
Table 15. Global Nonsteroidal Antiinflammatory Drugs Sales by Company (2020-2025) & (K Pcs)
Table 16. Global Nonsteroidal Antiinflammatory Drugs Sales Market Share by Company (2020-2025)
Table 17. Global Nonsteroidal Antiinflammatory Drugs Revenue by Company (2020-2025) & ($ millions)
Table 18. Global Nonsteroidal Antiinflammatory Drugs Revenue Market Share by Company (2020-2025)
Table 19. Global Nonsteroidal Antiinflammatory Drugs Sale Price by Company (2020-2025) & (USD/Pcs)
Table 20. Key Manufacturers Nonsteroidal Antiinflammatory Drugs Producing Area Distribution and Sales Area
Table 21. Players Nonsteroidal Antiinflammatory Drugs Products Offered
Table 22. Nonsteroidal Antiinflammatory Drugs Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Nonsteroidal Antiinflammatory Drugs Sales by Geographic Region (2020-2025) & (K Pcs)
Table 26. Global Nonsteroidal Antiinflammatory Drugs Sales Market Share Geographic Region (2020-2025)
Table 27. Global Nonsteroidal Antiinflammatory Drugs Revenue by Geographic Region (2020-2025) & ($ millions)
Table 28. Global Nonsteroidal Antiinflammatory Drugs Revenue Market Share by Geographic Region (2020-2025)
Table 29. Global Nonsteroidal Antiinflammatory Drugs Sales by Country/Region (2020-2025) & (K Pcs)
Table 30. Global Nonsteroidal Antiinflammatory Drugs Sales Market Share by Country/Region (2020-2025)
Table 31. Global Nonsteroidal Antiinflammatory Drugs Revenue by Country/Region (2020-2025) & ($ millions)
Table 32. Global Nonsteroidal Antiinflammatory Drugs Revenue Market Share by Country/Region (2020-2025)
Table 33. Americas Nonsteroidal Antiinflammatory Drugs Sales by Country (2020-2025) & (K Pcs)
Table 34. Americas Nonsteroidal Antiinflammatory Drugs Sales Market Share by Country (2020-2025)
Table 35. Americas Nonsteroidal Antiinflammatory Drugs Revenue by Country (2020-2025) & ($ millions)
Table 36. Americas Nonsteroidal Antiinflammatory Drugs Sales byType (2020-2025) & (K Pcs)
Table 37. Americas Nonsteroidal Antiinflammatory Drugs Sales by Application (2020-2025) & (K Pcs)
Table 38. APAC Nonsteroidal Antiinflammatory Drugs Sales by Region (2020-2025) & (K Pcs)
Table 39. APAC Nonsteroidal Antiinflammatory Drugs Sales Market Share by Region (2020-2025)
Table 40. APAC Nonsteroidal Antiinflammatory Drugs Revenue by Region (2020-2025) & ($ millions)
Table 41. APAC Nonsteroidal Antiinflammatory Drugs Sales byType (2020-2025) & (K Pcs)
Table 42. APAC Nonsteroidal Antiinflammatory Drugs Sales by Application (2020-2025) & (K Pcs)
Table 43. Europe Nonsteroidal Antiinflammatory Drugs Sales by Country (2020-2025) & (K Pcs)
Table 44. Europe Nonsteroidal Antiinflammatory Drugs Revenue by Country (2020-2025) & ($ millions)
Table 45. Europe Nonsteroidal Antiinflammatory Drugs Sales byType (2020-2025) & (K Pcs)
Table 46. Europe Nonsteroidal Antiinflammatory Drugs Sales by Application (2020-2025) & (K Pcs)
Table 47. Middle East & Africa Nonsteroidal Antiinflammatory Drugs Sales by Country (2020-2025) & (K Pcs)
Table 48. Middle East & Africa Nonsteroidal Antiinflammatory Drugs Revenue Market Share by Country (2020-2025)
Table 49. Middle East & Africa Nonsteroidal Antiinflammatory Drugs Sales byType (2020-2025) & (K Pcs)
Table 50. Middle East & Africa Nonsteroidal Antiinflammatory Drugs Sales by Application (2020-2025) & (K Pcs)
Table 51. Key Market Drivers & Growth Opportunities of Nonsteroidal Antiinflammatory Drugs
Table 52. Key Market Challenges & Risks of Nonsteroidal Antiinflammatory Drugs
Table 53. Key IndustryTrends of Nonsteroidal Antiinflammatory Drugs
Table 54. Nonsteroidal Antiinflammatory Drugs Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Nonsteroidal Antiinflammatory Drugs Distributors List
Table 57. Nonsteroidal Antiinflammatory Drugs Customer List
Table 58. Global Nonsteroidal Antiinflammatory Drugs SalesForecast by Region (2026-2031) & (K Pcs)
Table 59. Global Nonsteroidal Antiinflammatory Drugs RevenueForecast by Region (2026-2031) & ($ millions)
Table 60. Americas Nonsteroidal Antiinflammatory Drugs SalesForecast by Country (2026-2031) & (K Pcs)
Table 61. Americas Nonsteroidal Antiinflammatory Drugs Annual RevenueForecast by Country (2026-2031) & ($ millions)
Table 62. APAC Nonsteroidal Antiinflammatory Drugs SalesForecast by Region (2026-2031) & (K Pcs)
Table 63. APAC Nonsteroidal Antiinflammatory Drugs Annual RevenueForecast by Region (2026-2031) & ($ millions)
Table 64. Europe Nonsteroidal Antiinflammatory Drugs SalesForecast by Country (2026-2031) & (K Pcs)
Table 65. Europe Nonsteroidal Antiinflammatory Drugs RevenueForecast by Country (2026-2031) & ($ millions)
Table 66. Middle East & Africa Nonsteroidal Antiinflammatory Drugs SalesForecast by Country (2026-2031) & (K Pcs)
Table 67. Middle East & Africa Nonsteroidal Antiinflammatory Drugs RevenueForecast by Country (2026-2031) & ($ millions)
Table 68. Global Nonsteroidal Antiinflammatory Drugs SalesForecast byType (2026-2031) & (K Pcs)
Table 69. Global Nonsteroidal Antiinflammatory Drugs RevenueForecast byType (2026-2031) & ($ millions)
Table 70. Global Nonsteroidal Antiinflammatory Drugs SalesForecast by Application (2026-2031) & (K Pcs)
Table 71. Global Nonsteroidal Antiinflammatory Drugs RevenueForecast by Application (2026-2031) & ($ millions)
Table 72. Sanofi S.A. Basic Information, Nonsteroidal Antiinflammatory Drugs Manufacturing Base, Sales Area and Its Competitors
Table 73. Sanofi S.A. Nonsteroidal Antiinflammatory Drugs Product Portfolios and Specifications
Table 74. Sanofi S.A. Nonsteroidal Antiinflammatory Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 75. Sanofi S.A. Main Business
Table 76. Sanofi S.A. Latest Developments
Table 77. Novartis AG Basic Information, Nonsteroidal Antiinflammatory Drugs Manufacturing Base, Sales Area and Its Competitors
Table 78. Novartis AG Nonsteroidal Antiinflammatory Drugs Product Portfolios and Specifications
Table 79. Novartis AG Nonsteroidal Antiinflammatory Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 80. Novartis AG Main Business
Table 81. Novartis AG Latest Developments
Table 82. GlaxoSmithKline PLC Basic Information, Nonsteroidal Antiinflammatory Drugs Manufacturing Base, Sales Area and Its Competitors
Table 83. GlaxoSmithKline PLC Nonsteroidal Antiinflammatory Drugs Product Portfolios and Specifications
Table 84. GlaxoSmithKline PLC Nonsteroidal Antiinflammatory Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 85. GlaxoSmithKline PLC Main Business
Table 86. GlaxoSmithKline PLC Latest Developments
Table 87. Pfizer Basic Information, Nonsteroidal Antiinflammatory Drugs Manufacturing Base, Sales Area and Its Competitors
Table 88. Pfizer Nonsteroidal Antiinflammatory Drugs Product Portfolios and Specifications
Table 89. Pfizer Nonsteroidal Antiinflammatory Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 90. Pfizer Main Business
Table 91. Pfizer Latest Developments
Table 92. DOMESCO Basic Information, Nonsteroidal Antiinflammatory Drugs Manufacturing Base, Sales Area and Its Competitors
Table 93. DOMESCO Nonsteroidal Antiinflammatory Drugs Product Portfolios and Specifications
Table 94. DOMESCO Nonsteroidal Antiinflammatory Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 95. DOMESCO Main Business
Table 96. DOMESCO Latest Developments
LIST OFFIGURES
Figure 1. Picture of Nonsteroidal Antiinflammatory Drugs
Figure 2. Nonsteroidal Antiinflammatory Drugs Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Nonsteroidal Antiinflammatory Drugs Sales Growth Rate 2020-2031 (K Pcs)
Figure 7. Global Nonsteroidal Antiinflammatory Drugs Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Nonsteroidal Antiinflammatory Drugs Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Nonsteroidal Antiinflammatory Drugs Sales Market Share by Country/Region (2024)
Figure 10. Nonsteroidal Antiinflammatory Drugs Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Oral Nonsteroidal Antiinflammatory Drugs
Figure 12. Product Picture of Injection Nonsteroidal Antiinflammatory Drugs
Figure 13. Global Nonsteroidal Antiinflammatory Drugs Sales Market Share byType in 2025
Figure 14. Global Nonsteroidal Antiinflammatory Drugs Revenue Market Share byType (2020-2025)
Figure 15. Nonsteroidal Antiinflammatory Drugs Consumed in Osteoarthritis
Figure 16. Global Nonsteroidal Antiinflammatory Drugs Market: Osteoarthritis (2020-2025) & (K Pcs)
Figure 17. Nonsteroidal Antiinflammatory Drugs Consumed in Muscle Aches
Figure 18. Global Nonsteroidal Antiinflammatory Drugs Market: Muscle Aches (2020-2025) & (K Pcs)
Figure 19. Nonsteroidal Antiinflammatory Drugs Consumed in Backaches
Figure 20. Global Nonsteroidal Antiinflammatory Drugs Market: Backaches (2020-2025) & (K Pcs)
Figure 21. Nonsteroidal Antiinflammatory Drugs Consumed in Dental Pain
Figure 22. Global Nonsteroidal Antiinflammatory Drugs Market: Dental Pain (2020-2025) & (K Pcs)
Figure 23. Nonsteroidal Antiinflammatory Drugs Consumed in Others
Figure 24. Global Nonsteroidal Antiinflammatory Drugs Market: Others (2020-2025) & (K Pcs)
Figure 25. Global Nonsteroidal Antiinflammatory Drugs Sale Market Share by Application (2024)
Figure 26. Global Nonsteroidal Antiinflammatory Drugs Revenue Market Share by Application in 2025
Figure 27. Nonsteroidal Antiinflammatory Drugs Sales by Company in 2025 (K Pcs)
Figure 28. Global Nonsteroidal Antiinflammatory Drugs Sales Market Share by Company in 2025
Figure 29. Nonsteroidal Antiinflammatory Drugs Revenue by Company in 2025 ($ millions)
Figure 30. Global Nonsteroidal Antiinflammatory Drugs Revenue Market Share by Company in 2025
Figure 31. Global Nonsteroidal Antiinflammatory Drugs Sales Market Share by Geographic Region (2020-2025)
Figure 32. Global Nonsteroidal Antiinflammatory Drugs Revenue Market Share by Geographic Region in 2025
Figure 33. Americas Nonsteroidal Antiinflammatory Drugs Sales 2020-2025 (K Pcs)
Figure 34. Americas Nonsteroidal Antiinflammatory Drugs Revenue 2020-2025 ($ millions)
Figure 35. APAC Nonsteroidal Antiinflammatory Drugs Sales 2020-2025 (K Pcs)
Figure 36. APAC Nonsteroidal Antiinflammatory Drugs Revenue 2020-2025 ($ millions)
Figure 37. Europe Nonsteroidal Antiinflammatory Drugs Sales 2020-2025 (K Pcs)
Figure 38. Europe Nonsteroidal Antiinflammatory Drugs Revenue 2020-2025 ($ millions)
Figure 39. Middle East & Africa Nonsteroidal Antiinflammatory Drugs Sales 2020-2025 (K Pcs)
Figure 40. Middle East & Africa Nonsteroidal Antiinflammatory Drugs Revenue 2020-2025 ($ millions)
Figure 41. Americas Nonsteroidal Antiinflammatory Drugs Sales Market Share by Country in 2025
Figure 42. Americas Nonsteroidal Antiinflammatory Drugs Revenue Market Share by Country (2020-2025)
Figure 43. Americas Nonsteroidal Antiinflammatory Drugs Sales Market Share byType (2020-2025)
Figure 44. Americas Nonsteroidal Antiinflammatory Drugs Sales Market Share by Application (2020-2025)
Figure 45. United States Nonsteroidal Antiinflammatory Drugs Revenue Growth 2020-2025 ($ millions)
Figure 46. Canada Nonsteroidal Antiinflammatory Drugs Revenue Growth 2020-2025 ($ millions)
Figure 47. Mexico Nonsteroidal Antiinflammatory Drugs Revenue Growth 2020-2025 ($ millions)
Figure 48. Brazil Nonsteroidal Antiinflammatory Drugs Revenue Growth 2020-2025 ($ millions)
Figure 49. APAC Nonsteroidal Antiinflammatory Drugs Sales Market Share by Region in 2025
Figure 50. APAC Nonsteroidal Antiinflammatory Drugs Revenue Market Share by Region (2020-2025)
Figure 51. APAC Nonsteroidal Antiinflammatory Drugs Sales Market Share byType (2020-2025)
Figure 52. APAC Nonsteroidal Antiinflammatory Drugs Sales Market Share by Application (2020-2025)
Figure 53. China Nonsteroidal Antiinflammatory Drugs Revenue Growth 2020-2025 ($ millions)
Figure 54. Japan Nonsteroidal Antiinflammatory Drugs Revenue Growth 2020-2025 ($ millions)
Figure 55. South Korea Nonsteroidal Antiinflammatory Drugs Revenue Growth 2020-2025 ($ millions)
Figure 56. Southeast Asia Nonsteroidal Antiinflammatory Drugs Revenue Growth 2020-2025 ($ millions)
Figure 57. India Nonsteroidal Antiinflammatory Drugs Revenue Growth 2020-2025 ($ millions)
Figure 58. Australia Nonsteroidal Antiinflammatory Drugs Revenue Growth 2020-2025 ($ millions)
Figure 59. ChinaTaiwan Nonsteroidal Antiinflammatory Drugs Revenue Growth 2020-2025 ($ millions)
Figure 60. Europe Nonsteroidal Antiinflammatory Drugs Sales Market Share by Country in 2025
Figure 61. Europe Nonsteroidal Antiinflammatory Drugs Revenue Market Share by Country (2020-2025)
Figure 62. Europe Nonsteroidal Antiinflammatory Drugs Sales Market Share byType (2020-2025)
Figure 63. Europe Nonsteroidal Antiinflammatory Drugs Sales Market Share by Application (2020-2025)
Figure 64. Germany Nonsteroidal Antiinflammatory Drugs Revenue Growth 2020-2025 ($ millions)
Figure 65.France Nonsteroidal Antiinflammatory Drugs Revenue Growth 2020-2025 ($ millions)
Figure 66. UK Nonsteroidal Antiinflammatory Drugs Revenue Growth 2020-2025 ($ millions)
Figure 67. Italy Nonsteroidal Antiinflammatory Drugs Revenue Growth 2020-2025 ($ millions)
Figure 68. Russia Nonsteroidal Antiinflammatory Drugs Revenue Growth 2020-2025 ($ millions)
Figure 69. Middle East & Africa Nonsteroidal Antiinflammatory Drugs Sales Market Share by Country (2020-2025)
Figure 70. Middle East & Africa Nonsteroidal Antiinflammatory Drugs Sales Market Share byType (2020-2025)
Figure 71. Middle East & Africa Nonsteroidal Antiinflammatory Drugs Sales Market Share by Application (2020-2025)
Figure 72. Egypt Nonsteroidal Antiinflammatory Drugs Revenue Growth 2020-2025 ($ millions)
Figure 73. South Africa Nonsteroidal Antiinflammatory Drugs Revenue Growth 2020-2025 ($ millions)
Figure 74. Israel Nonsteroidal Antiinflammatory Drugs Revenue Growth 2020-2025 ($ millions)
Figure 75.Turkey Nonsteroidal Antiinflammatory Drugs Revenue Growth 2020-2025 ($ millions)
Figure 76. GCC Countries Nonsteroidal Antiinflammatory Drugs Revenue Growth 2020-2025 ($ millions)
Figure 77. Manufacturing Cost Structure Analysis of Nonsteroidal Antiinflammatory Drugs in 2025
Figure 78. Manufacturing Process Analysis of Nonsteroidal Antiinflammatory Drugs
Figure 79. Industry Chain Structure of Nonsteroidal Antiinflammatory Drugs
Figure 80. Channels of Distribution
Figure 81. Global Nonsteroidal Antiinflammatory Drugs Sales MarketForecast by Region (2026-2031)
Figure 82. Global Nonsteroidal Antiinflammatory Drugs Revenue Market ShareForecast by Region (2026-2031)
Figure 83. Global Nonsteroidal Antiinflammatory Drugs Sales Market ShareForecast byType (2026-2031)
Figure 84. Global Nonsteroidal Antiinflammatory Drugs Revenue Market ShareForecast byType (2026-2031)
Figure 85. Global Nonsteroidal Antiinflammatory Drugs Sales Market ShareForecast by Application (2026-2031)
Figure 86. Global Nonsteroidal Antiinflammatory Drugs Revenue Market ShareForecast by Application (2026-2031)
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Nonsteroidal Antiinflammatory Drugs Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Nonsteroidal Antiinflammatory Drugs by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Nonsteroidal Antiinflammatory Drugs by Country/Region, 2020, 2024 & 2031
2.2 Nonsteroidal Antiinflammatory Drugs Segment by Type
2.2.1 Oral Nonsteroidal Antiinflammatory Drugs
2.2.2 Injection Nonsteroidal Antiinflammatory Drugs
2.3 Nonsteroidal Antiinflammatory Drugs Sales by Type
2.3.1 Global Nonsteroidal Antiinflammatory Drugs Sales Market Share by Type (2020-2025)
2.3.2 Global Nonsteroidal Antiinflammatory Drugs Revenue and Market Share by Type (2020-2025)
2.3.3 Global Nonsteroidal Antiinflammatory Drugs Sale Price by Type (2020-2025)
2.4 Nonsteroidal Antiinflammatory Drugs Segment by Application
2.4.1 Osteoarthritis
2.4.2 Muscle Aches
2.4.3 Backaches
2.4.4 Dental Pain
2.4.5 Others
2.5 Nonsteroidal Antiinflammatory Drugs Sales by Application
2.5.1 Global Nonsteroidal Antiinflammatory Drugs Sale Market Share by Application (2020-2025)
2.5.2 Global Nonsteroidal Antiinflammatory Drugs Revenue and Market Share by Application (2020-2025)
2.5.3 Global Nonsteroidal Antiinflammatory Drugs Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Nonsteroidal Antiinflammatory Drugs Breakdown Data by Company
3.1.1 Global Nonsteroidal Antiinflammatory Drugs Annual Sales by Company (2020-2025)
3.1.2 Global Nonsteroidal Antiinflammatory Drugs Sales Market Share by Company (2020-2025)
3.2 Global Nonsteroidal Antiinflammatory Drugs Annual Revenue by Company (2020-2025)
3.2.1 Global Nonsteroidal Antiinflammatory Drugs Revenue by Company (2020-2025)
3.2.2 Global Nonsteroidal Antiinflammatory Drugs Revenue Market Share by Company (2020-2025)
3.3 Global Nonsteroidal Antiinflammatory Drugs Sale Price by Company
3.4 Key Manufacturers Nonsteroidal Antiinflammatory Drugs Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Nonsteroidal Antiinflammatory Drugs Product Location Distribution
3.4.2 Players Nonsteroidal Antiinflammatory Drugs Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR NONSTEROIDAL ANTIINFLAMMATORY DRUGS BY GEOGRAPHIC REGION
4.1 World Historic Nonsteroidal Antiinflammatory Drugs Market Size by Geographic Region (2020-2025)
4.1.1 Global Nonsteroidal Antiinflammatory Drugs Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Nonsteroidal Antiinflammatory Drugs Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Nonsteroidal Antiinflammatory Drugs Market Size by Country/Region (2020-2025)
4.2.1 Global Nonsteroidal Antiinflammatory Drugs Annual Sales by Country/Region (2020-2025)
4.2.2 Global Nonsteroidal Antiinflammatory Drugs Annual Revenue by Country/Region (2020-2025)
4.3 Americas Nonsteroidal Antiinflammatory Drugs Sales Growth
4.4 APAC Nonsteroidal Antiinflammatory Drugs Sales Growth
4.5 Europe Nonsteroidal Antiinflammatory Drugs Sales Growth
4.6 Middle East & Africa Nonsteroidal Antiinflammatory Drugs Sales Growth
5 AMERICAS
5.1 Americas Nonsteroidal Antiinflammatory Drugs Sales by Country
5.1.1 Americas Nonsteroidal Antiinflammatory Drugs Sales by Country (2020-2025)
5.1.2 Americas Nonsteroidal Antiinflammatory Drugs Revenue by Country (2020-2025)
5.2 Americas Nonsteroidal Antiinflammatory Drugs Sales by Type (2020-2025)
5.3 Americas Nonsteroidal Antiinflammatory Drugs Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Nonsteroidal Antiinflammatory Drugs Sales by Region
6.1.1 APAC Nonsteroidal Antiinflammatory Drugs Sales by Region (2020-2025)
6.1.2 APAC Nonsteroidal Antiinflammatory Drugs Revenue by Region (2020-2025)
6.2 APAC Nonsteroidal Antiinflammatory Drugs Sales by Type (2020-2025)
6.3 APAC Nonsteroidal Antiinflammatory Drugs Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Nonsteroidal Antiinflammatory Drugs by Country
7.1.1 Europe Nonsteroidal Antiinflammatory Drugs Sales by Country (2020-2025)
7.1.2 Europe Nonsteroidal Antiinflammatory Drugs Revenue by Country (2020-2025)
7.2 Europe Nonsteroidal Antiinflammatory Drugs Sales by Type (2020-2025)
7.3 Europe Nonsteroidal Antiinflammatory Drugs Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Nonsteroidal Antiinflammatory Drugs by Country
8.1.1 Middle East & Africa Nonsteroidal Antiinflammatory Drugs Sales by Country (2020-2025)
8.1.2 Middle East & Africa Nonsteroidal Antiinflammatory Drugs Revenue by Country (2020-2025)
8.2 Middle East & Africa Nonsteroidal Antiinflammatory Drugs Sales by Type (2020-2025)
8.3 Middle East & Africa Nonsteroidal Antiinflammatory Drugs Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Nonsteroidal Antiinflammatory Drugs
10.3 Manufacturing Process Analysis of Nonsteroidal Antiinflammatory Drugs
10.4 Industry Chain Structure of Nonsteroidal Antiinflammatory Drugs
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Nonsteroidal Antiinflammatory Drugs Distributors
11.3 Nonsteroidal Antiinflammatory Drugs Customer
12 WORLD FORECAST REVIEW FOR NONSTEROIDAL ANTIINFLAMMATORY DRUGS BY GEOGRAPHIC REGION
12.1 Global Nonsteroidal Antiinflammatory Drugs Market Size Forecast by Region
12.1.1 Global Nonsteroidal Antiinflammatory Drugs Forecast by Region (2026-2031)
12.1.2 Global Nonsteroidal Antiinflammatory Drugs Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Nonsteroidal Antiinflammatory Drugs Forecast by Type (2026-2031)
12.7 Global Nonsteroidal Antiinflammatory Drugs Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Sanofi S.A.
13.1.1 Sanofi S.A. Company Information
13.1.2 Sanofi S.A. Nonsteroidal Antiinflammatory Drugs Product Portfolios and Specifications
13.1.3 Sanofi S.A. Nonsteroidal Antiinflammatory Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Sanofi S.A. Main Business Overview
13.1.5 Sanofi S.A. Latest Developments
13.2 Novartis AG
13.2.1 Novartis AG Company Information
13.2.2 Novartis AG Nonsteroidal Antiinflammatory Drugs Product Portfolios and Specifications
13.2.3 Novartis AG Nonsteroidal Antiinflammatory Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Novartis AG Main Business Overview
13.2.5 Novartis AG Latest Developments
13.3 GlaxoSmithKline PLC
13.3.1 GlaxoSmithKline PLC Company Information
13.3.2 GlaxoSmithKline PLC Nonsteroidal Antiinflammatory Drugs Product Portfolios and Specifications
13.3.3 GlaxoSmithKline PLC Nonsteroidal Antiinflammatory Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 GlaxoSmithKline PLC Main Business Overview
13.3.5 GlaxoSmithKline PLC Latest Developments
13.4 Pfizer
13.4.1 Pfizer Company Information
13.4.2 Pfizer Nonsteroidal Antiinflammatory Drugs Product Portfolios and Specifications
13.4.3 Pfizer Nonsteroidal Antiinflammatory Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Pfizer Main Business Overview
13.4.5 Pfizer Latest Developments
13.5 DOMESCO
13.5.1 DOMESCO Company Information
13.5.2 DOMESCO Nonsteroidal Antiinflammatory Drugs Product Portfolios and Specifications
13.5.3 DOMESCO Nonsteroidal Antiinflammatory Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 DOMESCO Main Business Overview
13.5.5 DOMESCO Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OFTABLES
Table 1. Nonsteroidal Antiinflammatory Drugs Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Nonsteroidal Antiinflammatory Drugs Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Oral Nonsteroidal Antiinflammatory Drugs
Table 4. Major Players of Injection Nonsteroidal Antiinflammatory Drugs
Table 5. Global Nonsteroidal Antiinflammatory Drugs Sales byType (2020-2025) & (K Pcs)
Table 6. Global Nonsteroidal Antiinflammatory Drugs Sales Market Share byType (2020-2025)
Table 7. Global Nonsteroidal Antiinflammatory Drugs Revenue byType (2020-2025) & ($ million)
Table 8. Global Nonsteroidal Antiinflammatory Drugs Revenue Market Share byType (2020-2025)
Table 9. Global Nonsteroidal Antiinflammatory Drugs Sale Price byType (2020-2025) & (USD/Pcs)
Table 10. Global Nonsteroidal Antiinflammatory Drugs Sale by Application (2020-2025) & (K Pcs)
Table 11. Global Nonsteroidal Antiinflammatory Drugs Sale Market Share by Application (2020-2025)
Table 12. Global Nonsteroidal Antiinflammatory Drugs Revenue by Application (2020-2025) & ($ million)
Table 13. Global Nonsteroidal Antiinflammatory Drugs Revenue Market Share by Application (2020-2025)
Table 14. Global Nonsteroidal Antiinflammatory Drugs Sale Price by Application (2020-2025) & (USD/Pcs)
Table 15. Global Nonsteroidal Antiinflammatory Drugs Sales by Company (2020-2025) & (K Pcs)
Table 16. Global Nonsteroidal Antiinflammatory Drugs Sales Market Share by Company (2020-2025)
Table 17. Global Nonsteroidal Antiinflammatory Drugs Revenue by Company (2020-2025) & ($ millions)
Table 18. Global Nonsteroidal Antiinflammatory Drugs Revenue Market Share by Company (2020-2025)
Table 19. Global Nonsteroidal Antiinflammatory Drugs Sale Price by Company (2020-2025) & (USD/Pcs)
Table 20. Key Manufacturers Nonsteroidal Antiinflammatory Drugs Producing Area Distribution and Sales Area
Table 21. Players Nonsteroidal Antiinflammatory Drugs Products Offered
Table 22. Nonsteroidal Antiinflammatory Drugs Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Nonsteroidal Antiinflammatory Drugs Sales by Geographic Region (2020-2025) & (K Pcs)
Table 26. Global Nonsteroidal Antiinflammatory Drugs Sales Market Share Geographic Region (2020-2025)
Table 27. Global Nonsteroidal Antiinflammatory Drugs Revenue by Geographic Region (2020-2025) & ($ millions)
Table 28. Global Nonsteroidal Antiinflammatory Drugs Revenue Market Share by Geographic Region (2020-2025)
Table 29. Global Nonsteroidal Antiinflammatory Drugs Sales by Country/Region (2020-2025) & (K Pcs)
Table 30. Global Nonsteroidal Antiinflammatory Drugs Sales Market Share by Country/Region (2020-2025)
Table 31. Global Nonsteroidal Antiinflammatory Drugs Revenue by Country/Region (2020-2025) & ($ millions)
Table 32. Global Nonsteroidal Antiinflammatory Drugs Revenue Market Share by Country/Region (2020-2025)
Table 33. Americas Nonsteroidal Antiinflammatory Drugs Sales by Country (2020-2025) & (K Pcs)
Table 34. Americas Nonsteroidal Antiinflammatory Drugs Sales Market Share by Country (2020-2025)
Table 35. Americas Nonsteroidal Antiinflammatory Drugs Revenue by Country (2020-2025) & ($ millions)
Table 36. Americas Nonsteroidal Antiinflammatory Drugs Sales byType (2020-2025) & (K Pcs)
Table 37. Americas Nonsteroidal Antiinflammatory Drugs Sales by Application (2020-2025) & (K Pcs)
Table 38. APAC Nonsteroidal Antiinflammatory Drugs Sales by Region (2020-2025) & (K Pcs)
Table 39. APAC Nonsteroidal Antiinflammatory Drugs Sales Market Share by Region (2020-2025)
Table 40. APAC Nonsteroidal Antiinflammatory Drugs Revenue by Region (2020-2025) & ($ millions)
Table 41. APAC Nonsteroidal Antiinflammatory Drugs Sales byType (2020-2025) & (K Pcs)
Table 42. APAC Nonsteroidal Antiinflammatory Drugs Sales by Application (2020-2025) & (K Pcs)
Table 43. Europe Nonsteroidal Antiinflammatory Drugs Sales by Country (2020-2025) & (K Pcs)
Table 44. Europe Nonsteroidal Antiinflammatory Drugs Revenue by Country (2020-2025) & ($ millions)
Table 45. Europe Nonsteroidal Antiinflammatory Drugs Sales byType (2020-2025) & (K Pcs)
Table 46. Europe Nonsteroidal Antiinflammatory Drugs Sales by Application (2020-2025) & (K Pcs)
Table 47. Middle East & Africa Nonsteroidal Antiinflammatory Drugs Sales by Country (2020-2025) & (K Pcs)
Table 48. Middle East & Africa Nonsteroidal Antiinflammatory Drugs Revenue Market Share by Country (2020-2025)
Table 49. Middle East & Africa Nonsteroidal Antiinflammatory Drugs Sales byType (2020-2025) & (K Pcs)
Table 50. Middle East & Africa Nonsteroidal Antiinflammatory Drugs Sales by Application (2020-2025) & (K Pcs)
Table 51. Key Market Drivers & Growth Opportunities of Nonsteroidal Antiinflammatory Drugs
Table 52. Key Market Challenges & Risks of Nonsteroidal Antiinflammatory Drugs
Table 53. Key IndustryTrends of Nonsteroidal Antiinflammatory Drugs
Table 54. Nonsteroidal Antiinflammatory Drugs Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Nonsteroidal Antiinflammatory Drugs Distributors List
Table 57. Nonsteroidal Antiinflammatory Drugs Customer List
Table 58. Global Nonsteroidal Antiinflammatory Drugs SalesForecast by Region (2026-2031) & (K Pcs)
Table 59. Global Nonsteroidal Antiinflammatory Drugs RevenueForecast by Region (2026-2031) & ($ millions)
Table 60. Americas Nonsteroidal Antiinflammatory Drugs SalesForecast by Country (2026-2031) & (K Pcs)
Table 61. Americas Nonsteroidal Antiinflammatory Drugs Annual RevenueForecast by Country (2026-2031) & ($ millions)
Table 62. APAC Nonsteroidal Antiinflammatory Drugs SalesForecast by Region (2026-2031) & (K Pcs)
Table 63. APAC Nonsteroidal Antiinflammatory Drugs Annual RevenueForecast by Region (2026-2031) & ($ millions)
Table 64. Europe Nonsteroidal Antiinflammatory Drugs SalesForecast by Country (2026-2031) & (K Pcs)
Table 65. Europe Nonsteroidal Antiinflammatory Drugs RevenueForecast by Country (2026-2031) & ($ millions)
Table 66. Middle East & Africa Nonsteroidal Antiinflammatory Drugs SalesForecast by Country (2026-2031) & (K Pcs)
Table 67. Middle East & Africa Nonsteroidal Antiinflammatory Drugs RevenueForecast by Country (2026-2031) & ($ millions)
Table 68. Global Nonsteroidal Antiinflammatory Drugs SalesForecast byType (2026-2031) & (K Pcs)
Table 69. Global Nonsteroidal Antiinflammatory Drugs RevenueForecast byType (2026-2031) & ($ millions)
Table 70. Global Nonsteroidal Antiinflammatory Drugs SalesForecast by Application (2026-2031) & (K Pcs)
Table 71. Global Nonsteroidal Antiinflammatory Drugs RevenueForecast by Application (2026-2031) & ($ millions)
Table 72. Sanofi S.A. Basic Information, Nonsteroidal Antiinflammatory Drugs Manufacturing Base, Sales Area and Its Competitors
Table 73. Sanofi S.A. Nonsteroidal Antiinflammatory Drugs Product Portfolios and Specifications
Table 74. Sanofi S.A. Nonsteroidal Antiinflammatory Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 75. Sanofi S.A. Main Business
Table 76. Sanofi S.A. Latest Developments
Table 77. Novartis AG Basic Information, Nonsteroidal Antiinflammatory Drugs Manufacturing Base, Sales Area and Its Competitors
Table 78. Novartis AG Nonsteroidal Antiinflammatory Drugs Product Portfolios and Specifications
Table 79. Novartis AG Nonsteroidal Antiinflammatory Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 80. Novartis AG Main Business
Table 81. Novartis AG Latest Developments
Table 82. GlaxoSmithKline PLC Basic Information, Nonsteroidal Antiinflammatory Drugs Manufacturing Base, Sales Area and Its Competitors
Table 83. GlaxoSmithKline PLC Nonsteroidal Antiinflammatory Drugs Product Portfolios and Specifications
Table 84. GlaxoSmithKline PLC Nonsteroidal Antiinflammatory Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 85. GlaxoSmithKline PLC Main Business
Table 86. GlaxoSmithKline PLC Latest Developments
Table 87. Pfizer Basic Information, Nonsteroidal Antiinflammatory Drugs Manufacturing Base, Sales Area and Its Competitors
Table 88. Pfizer Nonsteroidal Antiinflammatory Drugs Product Portfolios and Specifications
Table 89. Pfizer Nonsteroidal Antiinflammatory Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 90. Pfizer Main Business
Table 91. Pfizer Latest Developments
Table 92. DOMESCO Basic Information, Nonsteroidal Antiinflammatory Drugs Manufacturing Base, Sales Area and Its Competitors
Table 93. DOMESCO Nonsteroidal Antiinflammatory Drugs Product Portfolios and Specifications
Table 94. DOMESCO Nonsteroidal Antiinflammatory Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 95. DOMESCO Main Business
Table 96. DOMESCO Latest Developments
LIST OFFIGURES
Figure 1. Picture of Nonsteroidal Antiinflammatory Drugs
Figure 2. Nonsteroidal Antiinflammatory Drugs Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Nonsteroidal Antiinflammatory Drugs Sales Growth Rate 2020-2031 (K Pcs)
Figure 7. Global Nonsteroidal Antiinflammatory Drugs Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Nonsteroidal Antiinflammatory Drugs Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Nonsteroidal Antiinflammatory Drugs Sales Market Share by Country/Region (2024)
Figure 10. Nonsteroidal Antiinflammatory Drugs Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Oral Nonsteroidal Antiinflammatory Drugs
Figure 12. Product Picture of Injection Nonsteroidal Antiinflammatory Drugs
Figure 13. Global Nonsteroidal Antiinflammatory Drugs Sales Market Share byType in 2025
Figure 14. Global Nonsteroidal Antiinflammatory Drugs Revenue Market Share byType (2020-2025)
Figure 15. Nonsteroidal Antiinflammatory Drugs Consumed in Osteoarthritis
Figure 16. Global Nonsteroidal Antiinflammatory Drugs Market: Osteoarthritis (2020-2025) & (K Pcs)
Figure 17. Nonsteroidal Antiinflammatory Drugs Consumed in Muscle Aches
Figure 18. Global Nonsteroidal Antiinflammatory Drugs Market: Muscle Aches (2020-2025) & (K Pcs)
Figure 19. Nonsteroidal Antiinflammatory Drugs Consumed in Backaches
Figure 20. Global Nonsteroidal Antiinflammatory Drugs Market: Backaches (2020-2025) & (K Pcs)
Figure 21. Nonsteroidal Antiinflammatory Drugs Consumed in Dental Pain
Figure 22. Global Nonsteroidal Antiinflammatory Drugs Market: Dental Pain (2020-2025) & (K Pcs)
Figure 23. Nonsteroidal Antiinflammatory Drugs Consumed in Others
Figure 24. Global Nonsteroidal Antiinflammatory Drugs Market: Others (2020-2025) & (K Pcs)
Figure 25. Global Nonsteroidal Antiinflammatory Drugs Sale Market Share by Application (2024)
Figure 26. Global Nonsteroidal Antiinflammatory Drugs Revenue Market Share by Application in 2025
Figure 27. Nonsteroidal Antiinflammatory Drugs Sales by Company in 2025 (K Pcs)
Figure 28. Global Nonsteroidal Antiinflammatory Drugs Sales Market Share by Company in 2025
Figure 29. Nonsteroidal Antiinflammatory Drugs Revenue by Company in 2025 ($ millions)
Figure 30. Global Nonsteroidal Antiinflammatory Drugs Revenue Market Share by Company in 2025
Figure 31. Global Nonsteroidal Antiinflammatory Drugs Sales Market Share by Geographic Region (2020-2025)
Figure 32. Global Nonsteroidal Antiinflammatory Drugs Revenue Market Share by Geographic Region in 2025
Figure 33. Americas Nonsteroidal Antiinflammatory Drugs Sales 2020-2025 (K Pcs)
Figure 34. Americas Nonsteroidal Antiinflammatory Drugs Revenue 2020-2025 ($ millions)
Figure 35. APAC Nonsteroidal Antiinflammatory Drugs Sales 2020-2025 (K Pcs)
Figure 36. APAC Nonsteroidal Antiinflammatory Drugs Revenue 2020-2025 ($ millions)
Figure 37. Europe Nonsteroidal Antiinflammatory Drugs Sales 2020-2025 (K Pcs)
Figure 38. Europe Nonsteroidal Antiinflammatory Drugs Revenue 2020-2025 ($ millions)
Figure 39. Middle East & Africa Nonsteroidal Antiinflammatory Drugs Sales 2020-2025 (K Pcs)
Figure 40. Middle East & Africa Nonsteroidal Antiinflammatory Drugs Revenue 2020-2025 ($ millions)
Figure 41. Americas Nonsteroidal Antiinflammatory Drugs Sales Market Share by Country in 2025
Figure 42. Americas Nonsteroidal Antiinflammatory Drugs Revenue Market Share by Country (2020-2025)
Figure 43. Americas Nonsteroidal Antiinflammatory Drugs Sales Market Share byType (2020-2025)
Figure 44. Americas Nonsteroidal Antiinflammatory Drugs Sales Market Share by Application (2020-2025)
Figure 45. United States Nonsteroidal Antiinflammatory Drugs Revenue Growth 2020-2025 ($ millions)
Figure 46. Canada Nonsteroidal Antiinflammatory Drugs Revenue Growth 2020-2025 ($ millions)
Figure 47. Mexico Nonsteroidal Antiinflammatory Drugs Revenue Growth 2020-2025 ($ millions)
Figure 48. Brazil Nonsteroidal Antiinflammatory Drugs Revenue Growth 2020-2025 ($ millions)
Figure 49. APAC Nonsteroidal Antiinflammatory Drugs Sales Market Share by Region in 2025
Figure 50. APAC Nonsteroidal Antiinflammatory Drugs Revenue Market Share by Region (2020-2025)
Figure 51. APAC Nonsteroidal Antiinflammatory Drugs Sales Market Share byType (2020-2025)
Figure 52. APAC Nonsteroidal Antiinflammatory Drugs Sales Market Share by Application (2020-2025)
Figure 53. China Nonsteroidal Antiinflammatory Drugs Revenue Growth 2020-2025 ($ millions)
Figure 54. Japan Nonsteroidal Antiinflammatory Drugs Revenue Growth 2020-2025 ($ millions)
Figure 55. South Korea Nonsteroidal Antiinflammatory Drugs Revenue Growth 2020-2025 ($ millions)
Figure 56. Southeast Asia Nonsteroidal Antiinflammatory Drugs Revenue Growth 2020-2025 ($ millions)
Figure 57. India Nonsteroidal Antiinflammatory Drugs Revenue Growth 2020-2025 ($ millions)
Figure 58. Australia Nonsteroidal Antiinflammatory Drugs Revenue Growth 2020-2025 ($ millions)
Figure 59. ChinaTaiwan Nonsteroidal Antiinflammatory Drugs Revenue Growth 2020-2025 ($ millions)
Figure 60. Europe Nonsteroidal Antiinflammatory Drugs Sales Market Share by Country in 2025
Figure 61. Europe Nonsteroidal Antiinflammatory Drugs Revenue Market Share by Country (2020-2025)
Figure 62. Europe Nonsteroidal Antiinflammatory Drugs Sales Market Share byType (2020-2025)
Figure 63. Europe Nonsteroidal Antiinflammatory Drugs Sales Market Share by Application (2020-2025)
Figure 64. Germany Nonsteroidal Antiinflammatory Drugs Revenue Growth 2020-2025 ($ millions)
Figure 65.France Nonsteroidal Antiinflammatory Drugs Revenue Growth 2020-2025 ($ millions)
Figure 66. UK Nonsteroidal Antiinflammatory Drugs Revenue Growth 2020-2025 ($ millions)
Figure 67. Italy Nonsteroidal Antiinflammatory Drugs Revenue Growth 2020-2025 ($ millions)
Figure 68. Russia Nonsteroidal Antiinflammatory Drugs Revenue Growth 2020-2025 ($ millions)
Figure 69. Middle East & Africa Nonsteroidal Antiinflammatory Drugs Sales Market Share by Country (2020-2025)
Figure 70. Middle East & Africa Nonsteroidal Antiinflammatory Drugs Sales Market Share byType (2020-2025)
Figure 71. Middle East & Africa Nonsteroidal Antiinflammatory Drugs Sales Market Share by Application (2020-2025)
Figure 72. Egypt Nonsteroidal Antiinflammatory Drugs Revenue Growth 2020-2025 ($ millions)
Figure 73. South Africa Nonsteroidal Antiinflammatory Drugs Revenue Growth 2020-2025 ($ millions)
Figure 74. Israel Nonsteroidal Antiinflammatory Drugs Revenue Growth 2020-2025 ($ millions)
Figure 75.Turkey Nonsteroidal Antiinflammatory Drugs Revenue Growth 2020-2025 ($ millions)
Figure 76. GCC Countries Nonsteroidal Antiinflammatory Drugs Revenue Growth 2020-2025 ($ millions)
Figure 77. Manufacturing Cost Structure Analysis of Nonsteroidal Antiinflammatory Drugs in 2025
Figure 78. Manufacturing Process Analysis of Nonsteroidal Antiinflammatory Drugs
Figure 79. Industry Chain Structure of Nonsteroidal Antiinflammatory Drugs
Figure 80. Channels of Distribution
Figure 81. Global Nonsteroidal Antiinflammatory Drugs Sales MarketForecast by Region (2026-2031)
Figure 82. Global Nonsteroidal Antiinflammatory Drugs Revenue Market ShareForecast by Region (2026-2031)
Figure 83. Global Nonsteroidal Antiinflammatory Drugs Sales Market ShareForecast byType (2026-2031)
Figure 84. Global Nonsteroidal Antiinflammatory Drugs Revenue Market ShareForecast byType (2026-2031)
Figure 85. Global Nonsteroidal Antiinflammatory Drugs Sales Market ShareForecast by Application (2026-2031)
Figure 86. Global Nonsteroidal Antiinflammatory Drugs Revenue Market ShareForecast by Application (2026-2031)
More Publications
Global Common Drugs Use in Ophthalmology Market Growth (Status and Outlook) 2023-2029
US$ 3,660.00
February 2023
111 pages
Global Phosphor Storage Plates Systems Market Growth 2023-2029
US$ 3,660.00
March 2023
106 pages
Global Walker Glide Skiies Market Growth 2024-2030
US$ 3,660.00
September 2024
109 pages
Global Silicone Facial Subcutaneous Implants Market Growth 2023-2029
US$ 3,660.00
March 2023
96 pages
Global Resorbable Lifting Thread Market Growth 2025-2031
US$ 3,660.00
April 2025
106 pages
